Células madre en la regeneración de tejidos: avances, aplicaciones clínicas y perspectivas biotecnológicas
Sapiens in Medicine Journal · 11.05.2026 · 4 (2) · 1-14
DOI: 10.71068/n7kkzv33 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sapiens in Medicine Journal, online erschienen am 11.05.2026. Verfasst von Daniela Anahí Baldeón Ríos und 3 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Stem cells constitute one of the most significant resources in contemporary regenerative medicine, characterized by their capacity for self-renewal and differentiation into multiple cell lineages, which positions them as therapeutic candidates for the restoration of damaged tissues. The general objective of this narrative review was to analyze the current state of stem cell use in tissue regeneration, integrating clinical and biotechnological perspectives to identify advances, limitations, and therapeutic opportunities. A literature search was conducted in PubMed, Scopus, and Google Scholar using terms related to stem cells, tissue engineering, and regenerative medicine, and 25 sources published between 2015 and 2026 were selected. The review examined key cell types (mesenchymal, induced pluripotent, and embryonic) and contemporary biotechnological tissue engineering techniques (scaffolds, hydrogels, and 3D bioprinting). Clinical applications in orthopedics, cardiology, neurology, and dermatology were analyzed, and the main ethical, technical, and regulatory challenges influencing their implementation were identified. The main results showed that: (i) iPSCs and 3D bioprinting represented the most promising advances in the field; (ii) mesenchymal stem cells garnered the most clinical evidence, showing significant pain reduction and functional improvement at 12–24 months in knee osteoarthritis; (iii) the ACCRUE meta-analysis did not demonstrate an overall significant benefit of post-infarction cell therapy regarding ejection fraction, though it identified subgroups that might derive benefit; (iv) transplantation of MHC-matched iPSCs improved neuronal engraftment in preclinical models of Parkinson's disease without tumor formation; and (v) exosome- and extracellular vesicle-based therapy emerged as an acellular alternative with cardioprotective properties. Finally, methodological, regulatory, and accessibility gaps persisted, limiting the routine clinical translation of these therapies.
Zitieren
APA
Ríos, D. A. B., Ríos, D. G. B., Espinoza, A. I. M., & Clas, O. M. V. (2026). Células madre en la regeneración de tejidos: avances, aplicaciones clínicas y perspectivas biotecnológicas. Sapiens in Medicine Journal, 4(2), 1-14. https://doi.org/10.71068/n7kkzv33
Vancouver
Ríos DAB, Ríos DGB, Espinoza AIM, Clas OMV. Células madre en la regeneración de tejidos: avances, aplicaciones clínicas y perspectivas biotecnológicas. Sapiens in Medicine Journal. 2026;4(2):1-14. doi:10.71068/n7kkzv33
BibTeX
@article{Ros2026,
author = {Ríos, Daniela Anahí Baldeón and Ríos, Diego Gabriel Baldeón and Espinoza, Ana Isabel Miguez and Clas, Odalis Mishell Velásquez},
title = {Células madre en la regeneración de tejidos: avances, aplicaciones clínicas y perspectivas biotecnológicas},
journal = {Sapiens in Medicine Journal},
year = {2026},
volume = {4},
number = {2},
pages = {1--14},
doi = {10.71068/n7kkzv33}
}
EUVIMED